A systems biology approach reveals the dose- and time-dependent effect of primary human airway epithelium tissue culture after exposure to cigarette smoke in vitro

Bioinformatics and Biology Insights

Volumn 9, Issue , 2015, Pages 19-35

  Mathis, Carole ^a   Gebel, Stephan ^b   Poussin, Carine ^a   Belcastro, Vincenzo ^a   Sewer, Alain ^a   Weisensee, Dirk ^b   Hengstermann, Arnd ^b   Ansari, Sam ^a   Wagner, Sandra ^a   Peitsch, Manuel C ^a   Hoeng, Julia ^a  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

^b Philip Morris Research Laboratories GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; EARLY GROWTH RESPONSE FACTOR 1; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 24; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; RAS PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR ELK 1;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION REGULATION; GLUTATHIONE METABOLISM; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; OXIDATIVE STRESS; PROTEIN SECRETION; PROTEIN TRANSPORT; RESPIRATORY EPITHELIUM; RNA ANALYSIS; RNA CAPPING; RNA PROCESSING; RNA SPLICING; RNA TRANSLATION; SIGNAL TRANSDUCTION; SMOKING; SYSTEMS BIOLOGY; TISSUE CULTURE; UPREGULATION; XENOBIOTIC METABOLISM; YOUNG ADULT;

EID: 84926472599     PISSN: None     EISSN: 11779322     Source Type: Journal    
DOI: 10.4137/bbi.s19908     Document Type: Article

References (82)

1. Hoeng J, Deehan R, Pratt D, etal. A network-based approach to quantifying the impact of biologically active substances. Drug Discov Today. 2012;17(9–10):413–8.
2. Mahadevan B, Snyder RD, Waters MD, etal. Genetic toxicology in the 21st century: reflections and future directions. Environ Mol Mutagen. 2011;52(5):339–54.
3. Stephens ML, Barrow C, Andersen ME, etal. Accelerating the development of 21st-century toxicology: outcome of a human toxicology project consortium workshop. Toxicol Sci. 2012;125(2):327–34.
4. NRC. Toxicity Testing in the 21st Century: A Vision and a Strategy. Washington DC: Natl Acad Press; 2007.
5. Coggins CR. A further review of inhalation studies with cigarette smoke and lung cancer in experimental animals, including transgenic mice. Inhal Toxicol. 2010;22(12):974–83.
6. Fehrenbach H. Animal models of chronic obstructive pulmonary disease: some critical remarks. Pathobiology. 2002;70(5):277–83.
7. Singh A, Misra V, Thimmulappa RK, etal. Dysfunctional KEAP1-NRF2interaction in non-small-cell lung cancer. PLoS Med. 2006;3(10):e420.
8. Rothen-Rutishauser B, Blank F, Muhlfeld C, Gehr P. In vitro models of the human epithelial airway barrier to study the toxic potential of particulate matter. Expert Opin Drug Metab Toxicol. 2008;4(8):1075–89.
9. Aufderheide M, Knebel JW, Ritter D. An improved in vitro model for testing the pulmonary toxicity of complex mixtures such as cigarette smoke. Exp Toxicol Pathol. 2003;55(1):51–7.
10. Aufderheide M, Scheffler S, Mohle N, Halter B, Hochrainer D. Analytical in vitro approach for studying cyto- and genotoxic effects of particulate airborne material. Anal Bioanal Chem. 2011;401(10):3213–20.
11. Olivera DS, Boggs SE, Beenhouwer C, Aden J, Knall C. Cellular mechanisms of mainstream cigarette smoke-induced lung epithelial tight junction permeability changes in vitro. Inhal Toxicol. 2007;19(1):13–22.
12. Phillips J, Kluss B, Richter A, Massey E. Exposure of bronchial epithelial cells to whole cigarette smoke: assessment of cellular responses. Altern Lab Anim. 2005;33(3):239–48.
13. Knorr-Wittmann C, Hengstermann A, Gebel S, Alam J, Muller T. Characterization of Nrf2 activation and heme oxygenase-1 expression in NIH3T3cells exposed to aqueous extracts of cigarette smoke. Free Radic Biol Med. 2005;39(11):1438–48.
14. Fields WR, Leonard RM, Odom PS, Nordskog BK, Ogden MW, Doolittle DJ. Gene expression in normal human bronchial epithelial (NHBE) cells following in vitro exposure to cigarette smoke condensate. Toxicol Sci. 2005;86(1):84–91.
15. Dvorak A, Tilley AE, Shaykhiev R, Wang R, Crystal RG. Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome? Am J Respir Cell Mol Biol. 2011;44(4):465–73.
16. Pezzulo AA, Starner TD, Scheetz TE, etal. The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia. Am J Physiol Lung Cell Mol Physiol. 2011;300(1):L25–31.
17. Balharry D, Sexton K, BeruBe KA. An in vitro approach to assess the toxicity of inhaled tobacco smoke components: nicotine, cadmium, formaldehyde and urethane. Toxicology. 2008;244(1):66–76.
18. Yoneda K, Peck K, Chang MM, etal. Development of high-density DNA microarray membrane for profiling smoke- and hydrogen peroxide-induced genes in a human bronchial epithelial cell line. Am J Respir Crit Care Med. 2001;164(10 pt 2):S85–9.
19. Sexton K, Balharry D, BeruBe KA. Genomic biomarkers of pulmonary exposure to tobacco smoke components. Pharmacogenet Genomics. 2008;18(10):853–60.
20. Lam HC, Choi AM, Ryter SW. Isolation of mouse respiratory epithelial cells and exposure to experimental cigarette smoke at air liquid interface. J Vis Exp. 2011;48. http://www.ncbi.nlm.nih.gov/pubmed/21372793
21. Mathis C, Poussin C, Weisensee D, etal. Human bronchial epithelial cells exposed in vitro to cigarette smoke at the air-liquid interface resemble bronchial epithelium from human smokers. Am J Physiol Lung Cell Mol Physiol. 2013;304(7):L489–503.
22. Maunders H, Patwardhan S, Phillips J, Clack A, Richter A. Human bronchial epithelial cell transcriptome: gene expression changes following acute exposure to whole cigarette smoke in vitro. Am J Physiol Lung Cell Mol Physiol. 2007;292(5):L1248–56.
23. Subramanian A, Tamayo P, Mootha VK, etal. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–50.
24. Catlett NL, Bargnesi AJ, Ungerer S, etal. Reverse causal reasoning: applying qualitative causal knowledge to the interpretation of high-throughput data. BMC Bioinformatics. 2013;14(1):340.
25. Schlage WK, Westra JW, Gebel S, etal. A computable cellular stress network model for non-diseased pulmonary and cardiovascular tissue. BMC Syst Biol. 2011;5:168.
26. Westra JW, Schlage WK, Frushour BP, etal. Construction of a computable cell proliferation network focused on non-diseased lung cells. BMC Syst Biol. 2011;5:105.
27. Westra JW, Schlage WK, Hengstermann A, etal. A modular cell-type focused inflammatory process network model for non-diseased pulmonary tissue. Bioinform Biol Insights. 2013;7:167–92.
28. Vergoulis T, Vlachos IS, Alexiou P, et al. TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res. 2012;40(Database issue):D222–9.
29. Weber S, Hebestreit M, Wilms T, Conroy LL, Rodrigo G. Comet assay and air-liquid interface exposure system: a new combination to evaluate genotoxic effects of cigarette whole smoke in human lung cell lines. Toxicol In Vitro. 2013;27(6):1987–91.
30. Smyth GK, Michaud J, Scott HS. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics. 2005;21(9):2067–75.
31. Belcastro V, Poussin C, Gebel S, etal. Systematic verification of upstream regulators of a computable cellular proliferation network model on non-diseased lung cells using a dedicated dataset. Bioinform Biol Insights. 2013;7:217–30.
32. Frey BJ, Dueck D. Clustering by passing messages between data points. Science. 2007;315(5814):972–6.
33. Hu QN, Deng Z, Hu H, Cao DS, Liang YZ. RxnFinder: biochemical reaction search engines using molecular structures, molecular fragments and reaction similarity. Bioinformatics. 2011;27(17):2465–7.
34. Bethune J, Artus-Revel CG, Filipowicz W. Kinetic analysis reveals successive steps leading to miRNA-mediated silencing in mammalian cells. EMBO Rep. 2012;13(8):716–23.
35. Nam JW, Rissland OS, Koppstein D, etal. Global analyses of the effect of different cellular contexts on microRNA targeting. Mol Cell. 2014;53(6):1031–43.
36. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466(7308):835–40.
37. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739–40.
38. Martin F, Thomson TM, Sewer A, etal. Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks. BMC Syst Biol. 2012;6:54.
39. Thomson TM, Sewer A, Martin F, etal. Quantitative assessment of biological impact using transcriptomic data and mechanistic network models. Toxicol Appl Pharmacol. 2013;272(3):863–78.
40. Gebel S, Diehl S, Pype J, etal. The transcriptome of Nrf2-/- mice provides evidence for impaired cell cycle progression in the development of cigarette smoke-induced emphysematous changes. Toxicol Sci. 2010;115(1):238–52.
41. Reddy SP. The antioxidant response element and oxidative stress modifiers in airway diseases. Curr Mol Med. 2008;8(5):376–83.
42. Dhakshinamoorthy S, Jain AK, Bloom DA, Jaiswal AK. Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H: quinone oxidoreductase 1gene expression and induction in response to antioxidants. J Biol Chem. 2005;280(17):16891–900.
43. Karin M, Shaulian E. AP-1: linking hydrogen peroxide and oxidative stress to the control of cell proliferation and death. IUBMB Life. 2001;52(1–2):17–24.
44. Luppi F, Aarbiou J, van Wetering S, et al. Effects of cigarette smoke condensate on proliferation and wound closure of bronchial epithelial cells in vitro: role of glutathione. Respir Res. 2005;6:140.
45. Kitamura M, Kasai A. Cigarette smoke as a trigger for the dioxin receptor-mediated signaling pathway. Cancer Lett. 2007;252(2):184–94.
46. Nebert DW, Dalton TP, Okey AB, Gonzalez FJ. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem. 2004;279(23):23847–50.
47. Hoeng J, Talikka M, Martin F, etal. Case study: the role of mechanistic network models in systems toxicology. Drug Discov Today. 2014;19(2):183–92.
48. Betsuyaku T, Hamamura I, Hata J, etal. Bronchiolar chemokine expression is different after single versus repeated cigarette smoke exposure. Respir Res. 2008;9:7.
49. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10(12):826–37.
50. Tolle LB, Standiford TJ. Danger-associated molecular patterns (DAMPs) in acute lung injury. J Pathol. 2013;229(2):145–56.
51. Gebel S, Muller T. The activity of NF-kappaB in Swiss 3T3cells exposed to aqueous extracts of cigarette smoke is dependent on thioredoxin. Toxicol Sci. 2001;59(1):75–81.
52. Loukili N, Rosenblatt-Velin N, Rolli J, etal. Oxidants positively or negatively regulate nuclear factor kappaB in a context-dependent manner. J Biol Chem. 2010;285(21):15746–52.
53. Lambert C, Li J, Jonscher K, et al. Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain. J Biol Chem. 2007;282(27):19666–75.
54. Allahverdian S, Harada N, Singhera GK, Knight DA, Dorscheid DR. Secretion of IL-13 by airway epithelial cells enhances epithelial repair via HB-EGF. Am J Respir Cell Mol Biol. 2008;38(2):153–60.
55. Gensch E, Gallup M, Sucher A, et al. Tobacco smoke control of mucin production in lung cells requires oxygen radicals AP-1 and JNK. J Biol Chem. 2004;279(37):39085–93.
56. Shen N, Gong T, Wang JD, et al. Cigarette smoke-induced pulmonary inflammatory responses are mediated by EGR-1/GGPPS/MAPK signaling. Am J Pathol. 2011;178(1):110–18.
57. Adcock IM, Caramori G, Barnes PJ. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 2011;81(4):265–84.
58. Sakamaki Y, Matsumoto K, Mizuno S, Miyoshi S, Matsuda H, Nakamura T. Hepatocyte growth factor stimulates proliferation of respiratory epithelial cells during postpneumonectomy compensatory lung growth in mice. Am J Respir Cell Mol Biol. 2002;26(5):525–33.
59. Ware LB, Matthay MA. Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol. 2002;282(5):L924–40.
60. Nadel JA. Mucous hypersecretion and relationship to cough. Pulm Pharmacol Ther. 2013;26(5):510–3.
61. Zhang Y, Jiang Y, Sun C, et al. The human cathelicidin LL-37 enhances airway mucus production in chronic obstructive pulmonary disease. Biochem Biophys Res Commun. 2014;443(1):103–9.
62. Cao R, Wang TT, DeMaria G, Sheehan JK, Kesimer M. Mapping the protein domain structures of the respiratory mucins: a mucin proteome coverage study. J Proteome Res. 2012;11(8):4013–23.
63. Finkbeiner WE, Zlock LT, Morikawa M, Lao AY, Dasari V, Widdicombe JH. Cystic fibrosis and the relationship between mucin and chloride secretion by cultures of human airway gland mucous cells. Am J Physiol Lung Cell Mol Physiol. 2011;301(4):L402–14.
64. Di YP, Zhao J, Harper R. Cigarette smoke induces MUC5AC protein expression through the activation of Sp1. J Biol Chem. 2012;287(33):27948–58.
65. Takeyama K, Jung B, Shim JJ, et al. Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol. 2001;280(1):L165–72.
66. An J, Li JQ, Wang T, et al. Blocking of thromboxane A(2) receptor attenuates airway mucus hyperproduction induced by cigarette smoke. Eur J Pharmacol. 2013;703(1–3):11–7.
67. Baginski TK, Dabbagh K, Satjawatcharaphong C, Swinney DC. Cigarette smoke synergistically enhances respiratory mucin induction by proinflammatory stimuli. Am J Respir Cell Mol Biol. 2006;35(2):165–74.
68. Glader P, Moller S, Lilja J, Wieslander E, Lofdahl CG, von Wachenfeldt K. Cigarette smoke extract modulates respiratory defence mechanisms through effects on T-cells and airway epithelial cells. Respir Med. 2006;100(5):818–27.
69. Xiao J, Wang K, Feng YL, Chen XR, Xu D, Zhang MK. Role of extracellular signal-regulated kinase 1/2in cigarette smoke-induced mucus hypersecretion in a rat model. Chin Med J (Engl). 2011;124(20):3327–33.
70. Boucherat O, Boczkowski J, Jeannotte L, Delacourt C. Cellular and molecular mechanisms of goblet cell metaplasia in the respiratory airways. Exp Lung Res. 2013;39(4–5):207–16.
71. Schembri F, Sridhar S, Perdomo C, et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci USA. 2009;106(7):2319–24.
72. Wang J, Lu M, Qiu C, Cui Q. TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Res. 2010;38(Database issue):D119–22.
73. O’Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol. 2011;11(3):163–75.
74. Leung AK, Sharp PA. MicroRNA functions in stress responses. Mol Cell. 2010;40(2):205–15.
75. Lize M, Klimke A, Dobbelstein M. MicroRNA-449in cell fate determination. Cell Cycle. 2011;10(17):2874–82.
76. Feng L, Xie Y, Zhang H, Wu Y. miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med Oncol. 2012;29(2):856–63.
77. Lee KH, Lotterman C, Karikari C, etal. Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology. 2009;9(3):293–301.
78. Takahashi Y, Forrest AR, Maeno E, Hashimoto T, Daub CO, Yasuda J. MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One. 2009;4(8):e6677.
79. Wang H, Wu J, Meng X, et al. MicroRNA-342inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis. 2011;32(7):1033–42.
80. Zhuang M, Gao W, Xu J, Wang P, Shu Y. The long non-coding RNA H19-derived miR-675modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun. 2014;448(3):315–22.
81. Sturla SJ, Boobis AR, FitzGerald RE, etal. Systems toxicology: from basic research to risk assessment. Chem Res Toxicol. 2014;27(3):314–29.
82. European Commission. Alternative testing strategies progress report. In: Commission E, ed. Replacing, Reducing, and Refining Use of Animals in Research. Brussels: European Commission; 2009:1–280.